Components of protective immunity

Advances in Experimental Medicine and Biology

Volumn 984, Issue , 2012, Pages 91-104

  Zhang, Guoquan ^a   Zhang, Yan ^a   Samuel, James E ^b  

^a UNIVERSITY OF MISSOURI   (United States)

^b TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

Antibody mediated immunity; Cell mediated immunity; Coxiella burnetii; Protective antigens; Protective immunity; Vaccine

Indexed keywords

BACTERIAL VACCINE; COXIELLA BURNETII PHASE I VACCINE; COXIELLA BURNETII PHASE II VACCINE; COXIELLA BURNETII PHASE IIV VACCINE; COXIELLA BURNETII PHASE IV VACCINE; Q FEVER VACCINE; Q VAX; UNCLASSIFIED DRUG;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY PRODUCTION; ARTICLE; CELLULAR IMMUNITY; COMPLEMENT SYSTEM; COXIELLA BURNETII; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG MEGADOSE; HOST PATHOGEN INTERACTION; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNITY; LOW DRUG DOSE; NONHUMAN; OPSONIZATION; PRIORITY JOURNAL; Q FEVER; T LYMPHOCYTE; UNSPECIFIED SIDE EFFECT; VACCINATION;

ANIMALS; BACTERIAL VACCINES; COXIELLA BURNETII; HUMANS; Q FEVER; VACCINATION;

BACTERIA (MICROORGANISMS); COXIELLA BURNETII;

EID: 84863733807     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-94-007-4315-1_5     Document Type: Article

References (63)

1. Abinanti FR, marmion BP (1957) Protective or neutralizing antibody in Q fever. Am J Hyg 66:173-195
2. Andoh M, Zhang G, Russell-Lodrigue KE, Shive HR, Weeks BR, Samuel JE (2007) T cells are essential for bacterial clearance, and gamma interferon, tumor necrosis factor alpha, and B cells are crucial for disease development in Coxiella burnetii infection in mice. Infect Immun 75:3245-3255
3. Ascher MS, Jahrling PB, Harrington DG, Kishimoto RA, Mcgann VG (1980) Mechanisms of protective immunogenicity of microbial vaccines: effects of cyclophosphamide pretreatment in Venezuelan encephalitis, Q fever and tularaemia. Clin Exp Immunol 41:225-236
4. Baca O, Akporiaye ET, Rowatt JD (1984) Possible biochemical adaptations of Coxiella burnetii for survival within phagocytes: effects of antibody. In: Leive L, Schlessinger D (eds) Microbiology. ASM Press, Washington DC, pp 269-272
5. Behymer DE, Biberstein EL, Riemann HP, Franti CE, Sawyer M (1975) Q fever ( Coxiella burnetii ) investigations in dairy cattle: persistence of antibodies after vaccination. Am J Vet Res 36:781-784
6. Bell EJ, Lackman DB, Meis A, Hadlow WJ (1964) Recurrent reaction at site of Q fever vaccination in a sensitized person. Milit Med 124:591-595
7. Brezina R, Kazar J (1965) Study of the antigenic structure of Coxiella burnetii. IV. Phagocytosis and opsonization in relation to the phase of C. burnetii . Acta Virol 9:268-274
8. Casadevall A, Pirofski LA (2004) New concepts in antibody-mediated immunity. Infect Immun 72:6191-6196
9. Dellacasagrande J, Capo C, Raoult D, Mege JL (1999) IFN-gamma-mediated control of Coxiella burnetii survival in monocytes: the role of cell apoptosis and TNF. J Immunol 162:2259-2265
10. Edelson BT, Cossart P, Unanue ER (1999) Cutting edge: paradigm revisited: antibody provides resistance to Listeria infection. J Immunol 163:4087-4090
11. Genig VA (1968) A live vaccine 1/M-44 against Q-fever for oral use. J Hyg Epid Microbiol Immunol 12:265-273
12. Germann T, Bongartz M, Dlugonska H, Hess H, Schmitt E, Kolbe L, Kölsch E, Podlaski FJ, Gately MK, Rüde E (1995) Interleukin-12 profoundly up-regulates the synthesis of antigen-speci fic complement- fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo . Eur J Immunol 25:823-829
13. Guigno D, Coupland B, Smith EG (1992) Primary humoral antibody response to Coxiella burnetii, the causative agent of Q fever. J Clin Microbiol 30:1958-1967
14. Hackstadt T, Peacock MG, Hitchcock PJ, Cole RL (1985) Lipopolysaccharide variation in Coxiella burnetti: intrastrain heterogeneity in structure and antigenicity. Infect Immun 48:359-365
15. Han Y, Cutler JE (1995) Antibody response that protects against disseminated candidiasis . Infect Immun 63:2714-2719
16. Hinrichs DJ, Jerrells TR (1976) In vitro evaluation of immunity to Coxiella burnetii . J Immunol 117:996-1003
17. Howe D, Barrows LF, Lindstrom NM, Heinzen RA (2002) Nitric oxide inhibits Coxiella burnetii replication and parasitophorous vacuole maturation. Infect Immun 70:5140-5147
18. Humphres RC, Hinrichs DJ (1981) Role of antibody in Coxiella burnetii infection. Infect Immun 31:641-645
19. Izzo AA, marmion BP (1993) Variation in interferon-gamma responses to Coxiella burnetii antigens with lymphocytes from vaccinated or naturally infected subjects. Clin Exp Immunol 94:507-515
20. Izzo AA, marmion BP, Worswick DA (1988) markers of cell-mediated immunity after vaccination with an inactivated, whole-cell Q fever vaccine. J Infect Dis 157:781-789
21. Izzo AA, marmion BP, Hackstadt T (1991) Analysis of the cells involved in the lymphoproliferative response to Coxiella burnetii antigens. Clin Exp Immunol 85:98-108
22. Kazar J, Skultetyova E, Brezina R (1975) Phagocytosis of Coxiella burnetii by macrophages. Acta Virol 19:426-431
23. Kazar J, El-Najdawi E, Brezina R, Schramek S (1977) Search for correlates of resistance to virulent challenge in mice immunized with Coxiella burnetii . Acta Virol 21:422-430
24. Kazar J, Brezina R, Palanova A, Tvrda B, Schramek S (1982) Immunogenicity and reactogenicity of a Q fever chemovaccine in persons professionally exposed to Q fever in Czechoslovakia. Bull WHO 60:389-394
25. Kishimoto RA, Burger GT (1977) Appearance of cellular and humoral immunity in guinea pigs after infection with Coxiella burnetii administered in small-particle aerosols. Infect Immun 16:518-521
26. Kishimoto RA, Walker JS (1976) Interaction between Coxiella burnetii and guinea pig peritoneal macrophages. Infect Immun 14:416-421
27. Kishimoto RA, Veltri BJ, Canonico PG, Shirey FG, Walker JS (1976) Electron microscopic study on the interaction between normal guinea pig peritoneal macrophages and Coxiella burnetii . Infect Immun 14:1087-1096
28. Kishimoto RA, Veltri BJ, Shirey FG, Canonico PG, Walker JS (1977) Fate of Coxiella burnetii in macrophages from immune guinea pigs. Infect Immun 15:601-607
29. Kishimoto RA, Johnson JW, Kenyon RH (1978) Cell-mediated immune responses of guinea pigs to an inactivated phase I Coxiella burnetii vaccine. Infect Immun 19:194-198
30. Koster FT, Kirkpatrick TL, Rowatt JD, Baca OG (1984) Antibody-dependent cellular cytotoxicity of Coxiella burnetii -infected J774 macrophage target cells. Infect Immun 43:253-256
31. Lackman DB, Frommhagen LH, Jensen FW, Lennette EH (1962) Q fever studies, 23, Antibody patterns against Coxiella burnetii . Am J Hyg 75:158-167
32. Li JS, Yager E, Reilly M, Freeman C, Reddy GR, Reilly AA, Chu FK, Winslow GM (2001) Outer membrane protein-speci fic monoclonal antibodies protect SCID mice from fatal infection by the obligate intracellular bacterial pathogen Ehrlichia chaffeensis . J Immunol 166:1855-1862
33. marmion BP, Ormsbee RA, Kyrkou M, Wright J, Worswick DA, Cameron S, Esterman A, Feery B, Collins W (1984) Vaccine prophylaxis of abattoir-associated Q fever. Lancet ii:1411-1414
34. marmion BP, Ormsbee RA, Kyrkou M, Wright J, Worswick DA, Izzo AA, Esterman A, Feery B, Shapiro RA (1990) Vaccine prophylaxis of abattoir-associated Q fever: eight years' experience in Australian abattoirs. Epidemiol Infect 104:275-287
35. Moore T, Ekworomadu CO, Eko FO, macMillan L, Ramey K, Ananaba GA, Patrickson JW, Nagappan PR, Lyn D, Black CM, Igietseme JU (2003) Fc receptor-mediated antibody regulation of T cell immunity against intracellular pathogens. J Infect Dis 188:617-624
36. Mukherjee J, Scharff MD, Casadevall A (1992) Protective murine monoclonal antibodies to Cryptococcus neoformans . Infect Immun 60:4534-4541
37. Neild AL, Roy CR (2004) Immunity to vacuolar pathogens: What can we learn from Legionella ? Cell Microbiol 6:1011-1018
38. Nosanchuk JD, Steenbergen JN, Shi L, Deepe GS, Casadevall A (2003) Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum . J Clin Invest 112:1164-1175
39. Ormsbee RA, Bell EJ, Lackman DB, Tallent G (1964) The in fluence of phase on the protective potency of Q fever vaccine. J Immunol 92:404-412
40. Pamer EG (2004) Immune responses to Listeria monocytogenes . Nat Rev Immunol 4:812-823
41. Peacock MG, Fiset P, Ormsbee RA, Wisseman CL (1979) Antibody response in man following a small intradermal inoculation with Coxiella burnetii phase I vaccine. Acta Virol 23:73-81
42. Peacock MG, Philip RN, Williams JC, Faulkner RS (1983) Serological evaluation of Q fever in humans: enhanced phase I titers of immunoglobulins G and A are diagnostic for Q fever endocarditis. Infect Immun 41:1089-1098
43. Podleski WK (1976) Cytodestructive mechanisms provoked by lymphocytes. Am J Med 61:1-8
44. Read AJ, Erickson S, Harmsen AG (2010) Role of CD4+ and CD8+ T cells in clearance of primary pulmonary infection with Coxiella burnetii . Infect Immun 78:3019-3026
45. Reece ST, Kaufmann SH (2008) Rational design of vaccines against tuberculosis directed by basic immunology. Int J Med Microbiol 298:143-150
46. Rosas AL, Nosanchuk JD, Casadevall A (2001) Passive immunization with melanin-binding monoclonal antibodies prolongs survival of mice with lethal Cryptococcus neoformans infection. Infect Immun 69:3410-3412
47. Shannon JG, Heinzen RA (2008) Infection of human monocyte-derived macrophages with Coxiella burnetii . Methods Mol Biol 431:189-200
48. Shannon JG, Cockrell DC, Takahashi K, Stahl GL, Heinzen RA (2009) Antibody-mediated immunity to the obligate intracellular bacterial pathogen Coxiella burnetii is Fc receptor- and complement-independent. BMC Immunol 10(26):1-8
49. Teitelbaum R, Glatman-Freedman A, Chen B, Robbins JB, Unanue E, Casadevall A, Bloom BR (1998) A mab recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival. PNAS 95:15688-15693
50. Turco J, Thompson HA, Winkler HH (1984) Interferon-gamma inhibits growth of Coxiella burnetii in mouse fibroblasts. Infect Immun 45:781-783
51. Waag DM, England MJ, Pitt ML (1997) Comparative ef ficacy of a Coxiella burnetii chloroform: methanol residue (CMR) vaccine and a licensed cellular vaccine (Q-Vax) in rodents challenged by aerosol. Vaccine 15:1779-1783
52. Waag DM, England MJ, Tammariello RF, Byrne WR, Gibbs P, Ban field CM, Pitt ML (2002) Comparative ef ficacy and immunogenicity of Q fever chloroform: methanol residue (CMR) and phase I cellular (Q-Vax) vaccines in cynomolgus monkeys challenged by aerosol. Vaccine 20:2623-2634
53. Williams JC, Hoover TA, Waag DM (1990) Antigenic structure of Coxiella burnetii. A comparison of lipopolysaccharide and protein antigens as vaccines against Q fever. Ann N Y Acad Sci 590:370-380
54. Williams JC, Peacock MG, Waag DM, Kent G, England MJ, Nelson G, Stephenson EH (1992) Vaccines against coxiellosis and Q fever Development of a chloroform:methanol residue subunit of phase I Coxiella burnetii for the immunization of animals. Ann N Y Acad Sci 653:88-111
55. Winslow GM, Yager E, Shilo K, Volk E, Reilly A, Chu FK (2000) Antibody-mediated elimination of the obligate intracellular bacterial pathogen Ehrlichia chaffeensis during active infection. Infect Immun 68:2187-2195
56. Woelbing F, Kostka SL, Moelle K, Belkaid Y, Sunderkoetter C, Verbeek S, Waisman A, Nigg AP, Knop J, Udey MC, Von Stebut E (2006) Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity. J Exp Med 203:177-188
57. Worswick D, marmion BP (1985) Antibody responses in acute and chronic Q fever and in subjects vaccinated against Q fever. J Med Microbiol 19:281-296
58. Yuan R, Clynes R, Oh J, Ravetch JV, Scharff MD (1998) Antibody-mediated modulation of Cryptococcus neoformans infection is dependent on distinct Fc receptor functions and IgG subclasses. J Exp Med 187:641-648
59. Zamboni DS, Rabinovitch M (2003) Nitric oxide partially controls Coxiella burnetii phase II infection in mouse primary macrophages. Infect Immun 71:1225-1233
60. Zhang G, Samuel JE (2003) Identi fication and cloning protective antigens of Coxiella burnetii recognized by sera from mice experimentally infected with Nine Mile phase I. Ann NY Acad Sci 990:510-521
61. Zhang YX, Zhi N, Yu SR (1994) Protective immunity induced by 67 K outer membrane protein of phase I Coxiella burnetii in mice and guinea pigs. Acta Virol 38:327-332
62. Zhang G, Kiss K, Seshadri R, Hendrix L, Samuel JE (2004) Identi fication and cloning of immunodominant antigens of Coxiella burnetii . Infect Immun 72:844-852
63. Zhang G, Russell-Lodrigue KE, Andoh M, Zhang Y, Hendrix LR, Samuel JE (2007) Mechanisms of vaccine-induced protective immunity against Coxiella burnetii infection in BALB/c mice. J Immunol 179:8372-8380